2026 Q2 Portfolio Activity
In 2026 Q2, TANG CAPITAL MANAGEMENT LLC maintained a portfolio of 56 distinct positions. The most significant new addition was NUVECTIS PHARMA INC, now representing 1.29% of the total fund value. They heavily accumulated shares in COMPASS PATHWAYS PLC, increasing the position by 24.9%. Conversely, TANG CAPITAL MANAGEMENT LLC completely exited their position in KALVISTA PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
Total Positions
56
Quarter
2026 Q2
Top Holding
AUPH (10.1%)
Top 10 Concentration
62.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 56
TANG CAPITAL MANAGEMENT LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AUPH
AURINIA PHARMAC...
|
Healthcare | 10.05% | 9.20% |
#1
Prev: #1
|
8.0 |
—
|
814,606 | 6.7% |
P
S
|
13,044,106 | $221,358,479 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 7.63% | 4.85% |
#2
7
Prev: #9
|
5.6 |
—
|
no change | no change |
P
S
|
1,892,200 | $167,989,516 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 6.57% | 5.80% |
#3
Prev: #3
|
4.6 |
—
|
no change | no change |
P
S
|
1,236,027 | $144,701,681 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 6.56% | 5.53% |
#4
2
Prev: #6
|
4.1 |
—
|
no change | no change |
P
S
|
2,259,889 | $144,519,902 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 6.25% | 6.09% |
#5
3
Prev: #2
|
5.5 |
—
|
264,594 | 25.2% |
P
S
|
1,314,594 | $137,532,824 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 5.92% | 3.07% |
#6
9
Prev: #15
|
3.4 |
—
|
no change | no change |
P
S
|
1,500,000 | $130,425,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 5.56% | 5.19% |
#7
1
Prev: #8
|
3.2 |
—
|
no change | no change |
P
S
|
1,500,000 | $122,355,000 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLPG
LAKEFRONT BIOTH...
|
Healthcare | 5.16% | 5.77% |
#8
4
Prev: #4
|
3.1 |
—
|
no change | no change |
P
S
|
3,785,991 | $113,504,010 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 4.48% | 5.25% |
#9
2
Prev: #7
|
4.3 |
—
|
700,000 | 20.6% |
P
S
|
4,099,900 | $98,725,592 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 4.48% | 4.23% |
#10
2
Prev: #12
|
4.3 |
—
|
379,642 | 31.9% |
P
S
|
1,568,266 | $98,706,662 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPY
STATE STR SPDR ...
|
ETF | 4.17% | 5.55% |
#11
6
Prev: #5
|
1.7 |
—
|
-45,000 | -26.8% |
P
S
|
123,000 | $91,852,710 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANAB
ANAPTYSBIO INC
|
Healthcare | 4.08% | 3.75% |
#12
2
Prev: #14
|
2.6 |
—
|
no change | no change |
P
S
|
1,330,879 | $89,834,333 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 3.82% | 4.06% |
#13
Prev: #13
|
2.5 |
—
|
no change | no change |
P
S
|
2,649,368 | $84,117,434 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 3.21% | 1.12% |
#14
9
Prev: #23
|
3.8 |
—
|
997,800 | 24.9% |
P
S
|
5,000,000 | $70,750,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 2.66% | 2.76% |
#15
1
Prev: #16
|
2.1 |
—
|
no change | no change |
P
S
|
707,500 | $58,566,850 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BNTX
BIONTECH SE
|
Healthcare | 1.99% | 2.12% |
#16
2
Prev: #18
|
1.8 |
—
|
no change | no change |
P
S
|
470,000 | $43,733,500 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.79% | 4.51% |
#17
6
Prev: #11
|
2.7 |
—
|
1,199,973 | 7.1% |
P
S
|
17,990,782 | $39,399,813 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PGEN
PRECIGEN INC
|
Healthcare | 1.66% | 1.26% |
#18
3
Prev: #21
|
1.7 |
—
|
no change | no change |
P
S
|
6,417,500 | $36,579,750 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.50% | 1.78% |
#19
Prev: #19
|
1.6 |
—
|
no change | no change |
P
S
|
1,792,626 | $32,930,540 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVCT
NUVECTIS PHARMA...
|
Healthcare | 1.29% | — |
#20
Prev: #—
|
4.0 |
—
|
1,550,000 | — |
NEW
|
1,550,000 | $28,504,500 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.17% | 1.13% |
#21
1
Prev: #22
|
1.5 |
—
|
no change | no change |
P
S
|
264,692 | $25,802,176 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 1.08% | — |
#22
Prev: #—
|
3.9 |
—
|
6,521,412 | — |
NEW
|
6,521,412 | $23,868,368 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVIR
ATEA PHARMACEUT...
|
Healthcare | 1.02% | 1.32% |
#23
3
Prev: #20
|
1.4 |
—
|
no change | no change |
P
S
|
4,814,700 | $22,388,355 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 0.95% | 1.08% |
#24
Prev: #24
|
1.4 |
—
|
no change | no change |
P
S
|
1,160,000 | $20,880,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
NNDM
NANO DIMENSION ...
|
Technology | 0.94% | — |
#25
Prev: #—
|
3.9 |
—
|
14,292,813 | — |
NEW
|
14,292,813 | $20,724,579 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.89% | 0.83% |
#26
Prev: #26
|
1.4 |
—
|
no change | no change |
P
S
|
500,000 | $19,505,000 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 0.85% | 0.69% |
#27
1
Prev: #28
|
0.8 |
—
|
150,000 | 4.8% |
P
S
|
3,299,557 | $18,741,484 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.76% | 0.76% |
#28
1
Prev: #27
|
1.3 |
—
|
no change | no change |
P
S
|
450,000 | $16,771,500 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
GOSSAMER BIO IN...
|
|
Bond/Debt | 0.52% | — |
#29
Prev: #—
|
3.7 |
—
|
17,841,000 | — |
NEW
|
17,841,000 | $11,468,373 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
DERM
JOURNEY MED COR...
|
Healthcare | 0.52% | 0.38% |
#30
Prev: #30
|
1.2 |
—
|
no change | no change |
P
S
|
1,610,000 | $11,398,800 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 0.48% | 2.16% |
#31
14
Prev: #17
|
0.2 |
—
|
-160,000 | -61.5% |
P
S
|
100,000 | $10,662,000 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 0.45% | 0.83% |
#32
7
Prev: #25
|
0.2 |
—
|
-200,000 | -40.0% |
P
S
|
300,000 | $9,816,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PLRX
PLIANT THERAPEU...
|
Healthcare | 0.32% | 0.39% |
#33
4
Prev: #29
|
0.6 |
—
|
-1,871 | -0.0% |
P
S
|
6,141,261 | $7,001,038 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BOLD
BOUNDLESS BIO I...
|
Healthcare | 0.29% | — |
#34
Prev: #—
|
3.6 |
—
|
2,559,875 | — |
NEW
|
2,559,875 | $6,399,688 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PMVP
PMV PHARMACEUTI...
|
Healthcare | 0.26% | 0.27% |
#35
Prev: #35
|
1.1 |
—
|
no change | no change |
P
S
|
4,245,085 | $5,688,414 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MRNA
MODERNA INC
|
Healthcare | 0.16% | 0.26% |
#36
Prev: #36
|
0.1 |
—
|
-50,000 | -50.0% |
P
S
|
50,000 | $3,501,500 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.16% | 0.22% |
#37
2
Prev: #39
|
1.1 |
—
|
no change | no change |
P
S
|
600,000 | $3,486,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HRTX
HERON THERAPEUT...
|
Healthcare | 0.12% | 0.25% |
#38
1
Prev: #37
|
1.0 |
—
|
no change | no change |
P
S
|
6,250,000 | $2,667,500 | 2014 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LENZ
LENZ THERAPEUTI...
|
Healthcare | 0.12% | 0.21% |
#39
1
Prev: #40
|
1.0 |
—
|
no change | no change |
P
S
|
451,114 | $2,562,328 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALT
ALTIMMUNE INC
|
Healthcare | 0.09% | 0.10% |
#40
5
Prev: #45
|
1.0 |
—
|
no change | no change |
P
S
|
666,022 | $2,024,707 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RCKT
ROCKET PHARMACE...
|
Healthcare | 0.02% | 0.02% |
#41
10
Prev: #51
|
1.0 |
—
|
no change | no change |
P
S
|
100,000 | $342,000 | 2018 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LXRX
LEXICON PHARMAC...
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #50) |
0.0 |
—
|
-399,700 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NMRA
NEUMORA THERAPE...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #49) |
0.0 |
—
|
-439,878 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FATE
FATE THERAPEUTI...
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #48) |
0.0 |
—
|
-1,167,773 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABEO
ABEONA THERAPEU...
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #47) |
0.0 |
—
|
-400,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #46) |
0.0 |
—
|
-483,021 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NKTX
NKARTA INC
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #44) |
0.0 |
—
|
-1,480,823 | -100.0% |
CLOSED
|
— | $— | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CHRS
COHERUS ONCOLOG...
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #43) |
0.0 |
—
|
-1,886,748 | -100.0% |
CLOSED
|
— | $— | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ERAS
ERASCA INC
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #42) |
0.0 |
—
|
-200,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #41) |
0.0 |
—
|
-100,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 56 holdings